The Nisshin OilliO Group (2602) FY2026 Q3 Earnings Report

Quick View

Executive Summary

Although cumulative Q3 results reflected higher revenue but lower earnings, the substantial increase in net income was primarily attributable to a one-time gain on the sale of fixed assets, indicating a decline in underlying earning power. Revenue increased to ¥4,169.6B (+3.1% YoY), while operating income declined to ¥135.2B (-20.2%) and ordinary income to ¥123.4B (-24.3%). Net income, however, rose significantly to ¥233.5B (+79.1%). The decline in operating income was primarily attributable to deteriorating profitability in the core Oils and Oilseeds Business and Processed Foods and Ingredients Business, while the increase in net income was driven by a ¥231.6B gain on the sale of fixed assets.

Factors Affecting Performance

【Revenue】Revenue was ¥4,169.6B, up +3.1% YoY. By region, Japan declined to ¥2,942.9B (-1.7% YoY), while Asia increased to ¥708.9B (+26.5%) and other regions grew to ¥517.8B (+6.0%), raising the overseas sales ratio to 29.4% from 25.9% in the previous year. By segment, the Global Oils and Processed Oils Business expanded to ¥1,114.8B (+17.7% YoY), while the core Oils and Oilseeds Business and Processed Foods and Ingredients Business declined slightly to ¥2,996.4B (-0.8%).

【Profit and Loss】Operating income was ¥135.2B (-20.2% YoY), and the operating margin declined to 3.2% from 4.2% in the previous year. Segment profit from the core businesses decreased substantially to ¥85.2B (-25.9% YoY), constituting the primary factor behind the decline in consolidated operating income. Despite higher revenue, the Global Oils and Processed Oils Business posted lower segment profit of ¥39.3B (-9.6% YoY), indicating that expansion in scale has not translated into higher earnings. Ordinary income was ¥123.4B (-24.3% YoY), weighed down by non-operating expenses including ¥23.0B in interest expense. Meanwhile, net income increased significantly to ¥233.5B (+79.1% YoY), driven by extraordinary income of ¥231.9B, including a ¥231.6B gain on the sale of fixed assets, a one-time factor. Even after recording an impairment loss of ¥15.7B, also a one-time factor, in the Oils and Oilseeds Business and Processed Foods and Ingredients Business, net income was still boosted. The divergence between ordinary income and net income was significantly affected by extraordinary gains and losses. In summary, the results reflected higher revenue but lower earnings.

Segment Analysis

The “Oils and Oilseeds Business and Processed Foods and Ingredients Business,” which made the largest contribution to segment profit, posted revenue of ¥2,996.4B (-0.8% YoY), segment profit of ¥85.2B (-25.9%), and a profit margin of 2.8%, highlighting a marked decline in earnings. By breakdown, Oils and Oilseeds generated ¥2,366.9B (-1.5% YoY), while Processed Foods and Ingredients generated ¥586.8B (+1.1%). The “Global Oils and Processed Oils Business” expanded revenue to ¥1,114.8B (+17.7% YoY), but segment profit declined to ¥39.3B (-9.6%), with the profit margin falling to 3.5%, indicating that higher revenue has not translated into higher profit. The “Fine Chemicals Business” generated revenue of ¥121.3B (+1.5% YoY) and segment profit of ¥12.9B (-0.2%), maintaining the highest profitability among the three businesses with a margin of 10.6%. The decline in earnings from the core businesses was the primary factor behind the decrease in consolidated operating income.

Key Financial Indicators

【Profitability】The operating margin was 3.2%, down from approximately 4.2% in the previous year, while the gross margin remained at 13.5%. The net profit margin was 5.6%, but it was significantly affected by extraordinary income including the gain on the sale of fixed assets; the ordinary-income-based margin of 2.96% is closer to the underlying performance of the core business.【Cash Flow Quality】Operating cash flow (OCF) was -¥14.7B, resulting in a negative ratio relative to net income of ¥233.5B, indicating limited conversion of earnings into cash. Accounts receivable increased by ¥125.6B and inventories by ¥42.9B, placing pressure on working capital.【Investment Efficiency】ROE was 10.7%, but excluding the impact of extraordinary income included in net income, the underlying return on capital is considered lower. Capital expenditures of ¥240.0B substantially exceeded depreciation and amortization of ¥85.9B, indicating a phase of growth investment.【Financial Soundness】The equity ratio was 48.9%, slightly down from 51.0% in the previous year but still at a high level. Current assets of ¥2,608.9B substantially exceeded current liabilities of ¥1,119.2B, ensuring short-term payment capacity.

Cash Flow Analysis

Operating cash flow deteriorated substantially to -¥14.7B from ¥100.7B in the same period of the previous year, creating a significant divergence from net income of ¥233.5B. The primary factors were increases of ¥125.6B in accounts receivable and ¥42.9B in inventories, indicating that working capital was tying up funds in line with revenue growth. Investing cash flow was -¥41.1B, with capital expenditures of ¥240.0B representing the primary use of funds; proceeds from the sale of fixed assets of ¥210.5B partially offset this outflow. Free cash flow was negative at -¥55.8B, indicating that investment could not be funded through operating activities alone. Financing cash flow was positive at ¥96.2B. The Company raised funds through ¥250.0B in long-term borrowings and ¥100.0B in bond issuance, while also returning capital to shareholders through ¥82.5B in share repurchases and ¥57.5B in dividend payments. Overall, the period reflected a structure in which investment and shareholder returns were funded through asset sales and external financing, making a recovery in operating cash flow a key focus going forward.

Earnings Quality

The increase in net income to ¥233.5B occurred despite a decline in ordinary income to ¥123.4B (-24.3% YoY), primarily due to extraordinary income of ¥231.9B, centered on a ¥231.6B gain on the sale of fixed assets. At the same time, the Company recorded extraordinary losses of ¥18.9B, including a ¥15.7B impairment loss in the Oils and Oilseeds Business and Processed Foods and Ingredients Business. Net extraordinary gains and losses reached ¥213.0B, accounting for more than half of pretax income of ¥336.4B. Non-operating income was relatively small at ¥18.7B, mainly consisting of ¥3.2B in dividend income, indicating limited depth as a recurring source of earnings. Given that operating cash flow was negative at -¥14.7B, the cash backing of current-period earnings was weak, indicating a divergence between reported earnings and actual cash-generating capacity. Comprehensive income was ¥332.5B, exceeding net income of ¥233.5B, primarily due to foreign currency translation adjustments of ¥71.2B; this does not indicate an improvement in the earning power of the business itself.

Earnings Forecast and Guidance

The full-year plan calls for revenue of ¥5,400.0B (+1.7% YoY), operating income of ¥150.0B (-22.2%), and ordinary income of ¥140.0B (-22.6%). The cumulative Q3 progress rates were 77.2% for revenue, 90.1% for operating income, and 88.2% for ordinary income, respectively. Although the progress rates for operating income and ordinary income exceed the standard 75% level, these rates may fluctuate toward Q4 depending on trends in raw material costs and price pass-through, given the declining earnings trend in the Oils and Oilseeds Business and Processed Foods and Ingredients Business. Against the EPS forecast of ¥763.19, cumulative Q3 EPS was ¥712.98, representing a progress rate of 93.4%; however, the significant contribution from extraordinary income should be noted.

Shareholder Returns

The full-year dividend forecast is ¥180 per share, implying a payout ratio of approximately 23.6% against full-year forecast EPS of ¥763.19. Dividend payments during cumulative Q3 totaled ¥57.5B, while operating cash flow for the same period was -¥14.7B and free cash flow was also negative at -¥55.8B, indicating that dividends could not be funded solely by internally generated cash during the period. Including ¥82.5B in share repurchases, total shareholder returns amounted to ¥139.9B, corresponding to a total return ratio of approximately 61.9% relative to net income attributable to owners of the parent of ¥225.9B. Retained earnings were substantial at ¥1,522.2B, ensuring short-term capacity for shareholder returns; however, improvement in operating cash flow will be an important consideration in assessing the sustainability of such returns.

Risk Factors

1. Structural low profitability and cost fluctuation risk: The gross margin of 13.5% and operating margin of 3.2% are low, and margins could come under further pressure if increases in raw material prices, foreign exchange rates, and logistics costs cannot be passed through to customers. Segment profit in the core businesses has already deteriorated by -25.9% YoY.

2. Working capital funding risk: Operating cash flow turned negative at -¥14.7B, while accounts receivable increased by ¥125.6B and inventories by ¥42.9B. If revenue growth continues without accompanying cash generation, the impact on liquidity management may increase.

3. Apparent uplift in ROE and ROIC due to dependence on extraordinary income: The ¥231.6B gain on the sale of fixed assets was the primary factor behind net income of ¥233.5B, and underlying return on capital excluding this gain is considered lower than ROE of 10.7% based on the core business. The repeatability of asset sales is limited.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (food_beverage)

Profitability and Returns

The operating margin is below the industry median, while the net profit margin exceeds the median partly due to the impact of extraordinary income.

Growth and Capital Efficiency

The revenue growth rate is broadly in line with the industry median.

※Source: Compiled by the Company

Key Takeaways from the Results

1. Overseas revenue, particularly revenue from Asia, expanded by +26.5% YoY, raising the overseas sales ratio to 29.4%. However, despite higher revenue, segment profit in the Global Oils and Processed Oils Business declined by -9.6%, indicating that scale growth and margin improvement have not been achieved simultaneously.

2. Q3 progress rates against the full-year operating income and ordinary income plans were 90.1% and 88.2%, respectively, exceeding the standard 75% level. However, given the decline in the operating margin and the shift to negative operating cash flow, the strength of earning power cannot be assessed solely from the high progress rates.

3. The substantial increase in net income was driven by a one-time factor centered on the gain on the sale of fixed assets. In assessing recurring earning power, trends in operating income, ordinary income, and operating cash flow are more important areas of observation.

Theoretical Share Price (Reference Value)

Sensitivity: ¥5,923–¥6,269 at ±1% for the cost of equity, and ¥6,060–¥6,113 at ±0.1 for ω.

Notes:

• Normalized EPS calculated from ordinary income and other items is used to exclude the impact of one-time gains and losses (the Company’s forecast EPS is ¥763.2).
• Amortization of goodwill of ¥1.4 per share is added back to earnings (as a non-cash expense and for comparability with IFRS companies).
• Because progress in net income against the full-year forecast is 96%, exceeding the standard level of 75%, forecast EPS is adjusted upward within a range capped at +10% (because companies ahead of plan tend to exceed forecasts; the adjustment may be excessive for businesses with strong seasonality).
• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest Rate Reference Month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, nor does it predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 performance was operationally weaker despite a sharp increase in reported net income, as the latter was driven predominantly by a large asset-sale gain. Revenue increased 3.1% year on year to ¥416.97bn. Operating income declined 20.2% to ¥13.52bn, while ordinary income fell 24.3% to ¥12.34bn. The operating margin compressed by 90bp to 3.2% from 4.2% in the prior-year period. Gross profit declined 3.8% to ¥56.45bn even though sales increased, reducing gross margin by 100bp to 13.5% from 14.5%. This indicates that higher sales did not translate into improved unit economics, consistent with the commodity-sensitive nature of the edible-oil business. SG&A rose 2.8% to ¥42.93bn, broadly tracking revenue but exacerbating the gross-profit shortfall at the operating-profit line. Net income attributable to owners rose 85.5% to ¥22.59bn, and EPS reached ¥712.98. However, extraordinary income of ¥23.19bn, almost entirely a ¥23.16bn gain on sale of fixed assets, exceeded reported net income before tax effects. The company also recognized a ¥1.57bn impairment loss in the Oils, Oilseeds, Processed Foods and Ingredients business, underscoring uneven asset profitability within the domestic-oriented portfolio. Operating cash flow was negative ¥1.47bn against net income attributable to owners of ¥22.59bn, resulting in an OCF/net-income ratio of negative 0.06x. Receivables increased by ¥12.56bn and inventories by ¥4.29bn, materially absorbing cash and pointing to working-capital pressure. Annualized inventory days were 84 days and DSO was 72 days, both above the respective 60-day alert thresholds. The balance sheet remains liquid, with a 233.1% current ratio and a 133.7% quick ratio, but the funding profile has become more leveraged as long-term loans rose 28.7% year on year to ¥65.13bn. Debt/EBITDA is elevated at 4.16x, though EBITDA interest coverage of 9.63x and debt/capital of 29.7% provide meaningful near-term debt-service capacity. Management's full-year forecast implies that Q3 cumulative progress is 77.2% for sales, 90.1% for operating income, 88.2% for ordinary income, and 96.1% for profit attributable to owners; the profit progress is inflated by the fixed-asset sale. The core investment debate is therefore whether margin recovery in oils and processed foods, together with normalization of inventory and receivables, can offset the loss of this non-recurring gain in the final quarter and thereafter.

Profitability Analysis

Annualized DuPont ROE is 13.9%, comprising a 5.4% net profit margin, 1.250x asset turnover, and 2.05x financial leverage. The reported ROE appears solid on the surface and sits within the 10-15% benchmark range, but the net margin is materially inflated by the ¥23.16bn fixed-asset disposal gain. Underlying operating profitability is more appropriately represented by the 3.2% EBIT margin and 5.3% EBITDA margin, both low for a branded food and ingredients group and below the 5% operating-margin concern threshold. The largest negative operating change was gross-margin compression: revenue increased 3.1%, whereas gross profit fell 3.8%, taking gross margin to 13.5%. This low gross margin is below the 25-40% food-industry reference range and reflects substantial exposure to commodity inputs and the comparatively low-margin oil and oilseed activities. SG&A increased 2.8%, slightly slower than revenue growth, so the main cause of operating-income decline was gross-profit deterioration rather than uncontrolled overhead growth. Interest expense rose to ¥2.30bn from ¥0.98bn, and the interest burden is distorted above 1.0x because pre-tax income includes extraordinary gains; it should not be interpreted as evidence that financing costs are immaterial. The tax burden was 0.672, equivalent to a 30.6% effective tax rate, which is broadly consistent with a normal Japanese corporate tax profile. EBITDA was ¥22.11bn, while goodwill amortization was only ¥0.03bn; JGAAP goodwill amortization therefore has no material effect on comparability with IFRS peers. Segment results identify Oils, Oilseeds, Processed Foods and Ingredients as the core business by operating-income contribution, generating ¥8.52bn of segment profit. Within that core business, Oils and Oilseeds earned ¥4.64bn, down 42.5% year on year, while Processed Foods and Ingredients earned ¥3.88bn, up 13.5%. Global Oils and Processed Oils reported revenue of ¥102.61bn, up 17.8%, but segment profit declined 9.6% to ¥3.93bn, indicating margin pressure despite growth. Fine Chemicals generated revenue of ¥11.34bn, up 4.0%, and segment profit of ¥1.29bn, essentially flat year on year; its segment margin of 11.4% remained substantially above the 3.6% margin of the core business. Other businesses recorded revenue of ¥7.65bn, down 5.1%, and segment profit of ¥0.50bn, down 14.0%. The ¥1.57bn impairment in the core business should be treated as a warning that some invested assets are failing to earn required returns, although it is a non-recurring charge rather than an operating-margin item.

Growth Assessment

Top-line growth was modest at 3.1%, with the geographic mix improving toward overseas markets. Japanese sales declined 1.7% to ¥294.29bn and represented 70.6% of revenue, down from 74.1% a year earlier. Asian sales increased 26.5% to ¥70.89bn, raising the regional mix to 17.0% from 13.9%. Sales in other regions rose 6.0% to ¥51.78bn, or 12.4% of revenue. The international expansion profile is therefore constructive, particularly in Asia, but global oils sales growth has not yet converted into segment-profit growth. Domestic demand and profitability remain important because Japan still accounts for more than 70% of consolidated sales. The core business's segment profit contracted 20.0% to ¥8.52bn despite broadly stable revenue of ¥295.36bn, demonstrating that pricing, product mix, and input-cost pass-through require improvement. Processed Foods and Ingredients was the favorable exception, with profit growth of 13.5%, which supports the strategic value of higher-value-added food, wellness, and ingredient categories. The full-year sales forecast of ¥540.00bn implies Q3 progress of 77.2%, modestly above the normal 75% run rate. Operating-income progress is 90.1% versus a normal 75%, and ordinary-income progress is 88.2%, suggesting the forecast is conservatively set, a favorable Q4 seasonal mix, or potential normalization in costs. Full-year profit attributable to owners progress is 96.1%, but this is not indicative of recurring outperformance because the quarter contains the unusually large asset-sale gain. The full-year guidance calls for sales growth of 1.7% and operating-income decline of 22.2%, consistent with management already anticipating continued pressure on underlying profitability. Food-industry growth risks include volatility in edible-oil and oilseed costs, foreign-exchange movements on imported inputs, energy and packaging costs, retailer/private-brand competition, and the need to maintain consumer pricing without damaging volumes.

Financial Health

Liquidity is strong on reported balances: current assets of ¥260.89bn exceed current liabilities of ¥111.92bn, producing a current ratio of 233.1% and working capital of ¥148.97bn. The quick ratio of 133.7% also exceeds 1.0x, indicating that near-term obligations are covered without relying entirely on inventory liquidation. Cash and deposits of ¥18.02bn cover 0.67x of short-term loans of ¥26.86bn, but receivables of ¥109.83bn and inventories of ¥111.24bn are the principal sources of current-asset liquidity. Accordingly, liquidity is adequate but is sensitive to collection and inventory normalization. Interest-bearing debt totals ¥91.99bn, consisting of ¥26.86bn of short-term loans, ¥65.13bn of long-term loans, and ¥25.00bn of bonds. The short-term debt ratio is 29.2%, limiting immediate maturity-mismatch risk because most debt is long dated and current assets substantially exceed short-term liabilities. Debt-to-equity is 1.05x, above a conservative 1.0x level but well below the 2.0x aggressive-leverage warning threshold. Debt/capital is 29.7%, which remains within the sub-40% investment-grade reference range. Nevertheless, the high-leverage alert is valid: debt/EBITDA of 4.16x is above the 4.0x threshold and leaves less room for a further operating-profit decline or sustained high investment. EBITDA interest coverage is 9.63x and EBIT interest coverage is 5.89x, so present interest-servicing capacity remains sound. Long-term loans increased ¥14.51bn, or 28.7%, year on year, while bonds payable increased ¥10.00bn to ¥25.00bn; financing has supported investment and shareholder distributions. Treasury stock expanded from negative ¥4.04bn to negative ¥12.31bn, reflecting ¥8.25bn of share repurchases during the period. Retained earnings increased ¥16.82bn to ¥152.22bn, aided by the non-recurring gain. Total equity increased to ¥217.32bn, but the capital adequacy ratio declined to 46.2% from 48.2% as asset and liability growth outpaced equity. Goodwill is only ¥0.13bn, or 0.1% of equity, and therefore acquisition accounting and goodwill impairment are not material balance-sheet risks. The recorded impairment relates to tangible operating assets rather than a material goodwill balance.

Notable B/S Changes

Long-term loans: +¥14.51bn (+28.7%) to ¥65.13bn — leverage increased alongside elevated capex, buybacks, and funding needs; monitor Debt/EBITDA and refinancing discipline. Treasury stock: expanded by ¥8.27bn to negative ¥12.31bn (-204.4%) — reflects ¥8.25bn of share repurchases, increasing capital-return intensity while free cash flow was negative. Property, plant and equipment: +¥21.53bn (+19.5%) to ¥131.81bn — consistent with the heavy investment cycle; the associated return and cash-generation profile require monitoring. Inventories: +¥7.96bn (+7.7%) to ¥111.24bn — together with 84 annualized inventory days, this increases commodity and working-capital exposure. Accounts receivable: +¥14.84bn (+15.6%) to ¥109.83bn — DSO of 72 days points to a slower cash-conversion cycle and elevates collection monitoring needs. Bonds payable: +¥10.00bn (+66.7%) to ¥25.00bn — incremental debt funding supports liquidity but contributes to the elevated 4.16x Debt/EBITDA ratio. Land: +¥12.98bn (+47.2%) to ¥40.45bn — asset composition changed materially alongside the ¥23.16bn fixed-asset disposal gain; future asset productivity should be assessed.

Cash Flow Quality

Cash-flow quality is the principal financial concern. Operating cash flow was negative ¥1.47bn, compared with ¥22.59bn of net income attributable to owners, resulting in an OCF/net-income ratio of negative 0.06x versus the 0.8x quality-warning threshold. Cash conversion was negative 0.07x of EBITDA, far below the 0.7x alert level. The divergence is partly explained by the non-cash or investing-related character of the ¥23.16bn gain on sale of fixed assets, which increased accounting earnings but did not represent operating cash generation. Working capital also absorbed substantial cash: trade receivables increased by ¥12.56bn and inventories increased by ¥4.29bn, partly offset by a ¥0.38bn increase in trade payables. DSO of 72 days exceeds the 60-day threshold, raising collection-cycle and customer-credit-monitoring importance. Annualized inventory days of 84 also exceed 60 days, signaling a significant working-capital burden and potential exposure to commodity-price movements, inventory valuation, and demand forecasting. The 5.4% accruals ratio is moderately elevated relative to a sub-5% high-quality reference but is not by itself an extreme warning; the more material issue is the exceptional-item and working-capital-driven cash shortfall. Reported free cash flow was negative ¥55.80bn. Capital expenditures were ¥24.00bn, equivalent to 2.80x depreciation and amortization of ¥8.59bn, indicating an expansionary investment cycle rather than underinvestment. Investing cash flow was only negative ¥4.12bn because proceeds from fixed-asset sales were ¥210.53bn, substantially offsetting capital expenditure and other investing outflows. This asset monetization supported cash generation in the period but cannot be assumed to recur at the same scale. Financing cash flow was positive ¥9.62bn, including ¥25.00bn of new long-term borrowing and ¥10.00bn of bond issuance, while the company also spent ¥8.25bn on repurchases and paid ¥5.75bn of cash dividends. The combination of negative operating cash flow, elevated capital spending, and shareholder distributions makes debt-funded capital allocation a key item to monitor.

Dividend Sustainability

The indicated full-year dividend is ¥180 per share, comprising the ¥90 interim dividend and a presumed ¥90 year-end dividend. Based on full-year forecast EPS of ¥763.19, the forward dividend payout ratio is approximately 23.6%, which is conservative and well below the 60% sustainability benchmark. The reported Q2 dividend of ¥90 per share represented a 13.4% payout ratio against Q3 cumulative earnings, but this denominator includes the large asset-sale gain and is therefore not a reliable measure of recurring payout capacity. Cash dividend payments during the period were ¥5.75bn, while share repurchases were ¥8.25bn. Using these payments and net income attributable to owners of ¥22.59bn, the cumulative total return ratio was approximately 62%, below the 80% sustainability reference. However, free cash flow was negative ¥55.80bn and FCF coverage of dividends was negative 1.84x, so cash coverage is weak in the current period. The dividend is nevertheless supported by strong current liquidity, a moderate 23.6% forecast payout ratio, and access to debt markets. The key limitation is that operating cash flow must recover as receivables and inventories normalize; otherwise, ongoing capex, dividends, and buybacks would continue to rely on asset sales or additional financing. Given Debt/EBITDA of 4.16x, discretionary repurchases warrant closer scrutiny than the ordinary dividend. The dividend policy outlook is therefore financially manageable on earnings, but its cash-flow sustainability depends on improved operating cash conversion.

Risk Assessment

Business risks include High priority — commodity-cost and pricing risk: the 13.5% gross margin, down 100bp year on year and below food-industry norms, exposes earnings to edible-oil, oilseed, energy, packaging, and foreign-exchange volatility if cost pass-through lags., High priority — core-business execution risk: the Oils, Oilseeds, Processed Foods and Ingredients segment generated ¥8.52bn of profit, down 20.0%, and included a ¥1.57bn impairment loss, indicating pressure on asset productivity and profitability., Medium priority — international expansion conversion risk: Asian revenue grew 26.5% to ¥70.89bn, but Global Oils and Processed Oils profit declined 9.6% despite 17.8% sales growth, showing that revenue expansion has not consistently translated into margin expansion., Medium priority — food-industry demand and brand risk: private-label competition, changing household demographics, food-safety incidents, retailer bargaining power, and consumer response to price increases can pressure volumes and pricing..

Financial risks include High priority — cash-conversion risk: negative ¥1.47bn operating cash flow, negative 0.06x OCF/net income, and negative 0.07x OCF/EBITDA indicate that reported earnings are not currently converting to cash., High priority — working-capital risk: receivables rose ¥12.56bn and inventories rose ¥4.29bn; DSO of 72 days and annualized inventory days of 84 are above alert thresholds., Medium priority — leverage risk: Debt/EBITDA of 4.16x exceeds the 4.0x high-leverage threshold, following increases in long-term loans and bonds, although interest coverage remains adequate., Medium priority — capital-allocation risk: negative free cash flow, ¥24.00bn of capex, ¥8.25bn of buybacks, and ¥5.75bn of dividends increase reliance on financing and asset-sale proceeds..

Key concerns include Reported net income is not representative of recurring profitability because extraordinary income of ¥23.19bn, principally a ¥23.16bn fixed-asset sale gain, equaled 110.9% of net income attributable to owners., The 13.9% annualized ROE is elevated by this one-time gain and 2.05x financial leverage; the 3.2% EBIT margin and 4.3% ROIC provide a more cautious view of ongoing capital efficiency., Low gross margin, low operating efficiency, high receivable days, high inventory days, low cash conversion, and high leverage jointly raise sensitivity to any deterioration in commodity costs, demand, or customer collections., The gain on sale of fixed assets improved reported profit and investing cash flow, but it does not solve the underlying operating-cash-flow deficit..

Investment Implications

Key takeaways include Sales growth and overseas mix expansion are positive, particularly Asia's 26.5% revenue growth, but group operating earnings are declining., The core business remains the primary earnings driver, yet its ¥8.52bn segment profit declined 20.0%; recovery in oils and oilseeds margins is central to future recurring earnings., Fine Chemicals remains the highest-margin disclosed segment at 11.4%, offering portfolio diversification, but its ¥1.29bn profit contribution is modest relative to the core business., The reported earnings increase is non-recurring, driven by a ¥23.16bn gain on sale of fixed assets, and should not be extrapolated into normalized profitability., Liquidity and interest coverage are adequate, but Debt/EBITDA of 4.16x and negative operating cash flow constrain financial flexibility if working capital remains elevated..

Metrics to watch include Gross margin and operating margin, especially evidence that commodity-cost increases are being passed through without volume deterioration., Core-business segment profit in Oils, Oilseeds, Processed Foods and Ingredients, including whether the impairment signals further asset rationalization., Operating cash flow, OCF/net income, DSO, annualized inventory days, and the pace of receivable and inventory normalization., Debt/EBITDA, long-term borrowing, bond issuance, and interest coverage after the current period's financing increase., Capex relative to depreciation, the recurrence of asset-sale proceeds, and the level of share repurchases while free cash flow is negative., Progress against full-year guidance: Q3 cumulative sales are 77.2%, operating income 90.1%, ordinary income 88.2%, and attributable profit 96.1% of forecast..

Regarding relative positioning, Nisshin Oillio combines a large, low-margin, commodity-exposed oils platform with a smaller but higher-margin fine-chemicals operation and growing overseas revenue. Its balance-sheet liquidity is stronger than its cash-conversion profile, while negligible goodwill reduces M&A-related impairment risk. Relative operating quality is constrained by a 13.5% gross margin, 3.2% EBIT margin, 4.3% ROIC, and elevated 4.16x Debt/EBITDA; the near-term financial narrative therefore depends more on recurring margin and cash recovery than on the reported headline net-income growth.